Mission and Goals


The Cancer Genomics Consortium (CGC) was formed in August, 2009 by a group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinical cancer genomics.

Mission Statement

The Cancer Genomics Consortium (CGC) is committed to providing high quality education and promoting best laboratory practices in clinical cancer genomics.


  • To provide expert and comprehensive knowledge of underlying genomic alterations to help manage individuals with, or at risk of, cancer.
  • To provide an innovative educational forum for the better utilization of genomic technologies for clinical laboratory testing.
  • To develop best practices for genomic laboratory testing in the evaluation of neoplasia.
  • To generate real time curated resources for clinical genomic testing
  • To promote and facilitate multi-center genomic cancer translational research.
  • To value and support the intersection of cancer and constitutional testing.
  • To promote and provide diversity, equity, and inclusion at all levels of the organization.

Vision Statement

All cancer patients will be accurately diagnosed for their underlying genomic alterations to help them receive the most appropriate therapy.

CGC will be the authoritative organization for guidance on the best practice of clinical cancer genomic testing.